Chapter

Health insurance and the uptake of new drugs in the United States

Marin Gemmill, Victoria Serra-Sastre and Joan Costa-Font

in The Economics of New Health Technologies

Published in print May 2009 | ISBN: 9780199550685
Published online February 2010 | e-ISBN: 9780191720543 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780199550685.003.0007
 Health insurance and the uptake of new drugs in the United States

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology

GO

Show Summary Details

Preview

This chapter investigates the effect of health insurance coverage on the use of relatively new prescription drugs. It focuses on statins, a class of lipid-lowering drugs that were considered a major breakthrough after a number of important clinical trials were published. The chapter is organized as follows: Section 2firstly it briefly reviews the literature on technology diffusion and the relationship between insurance and consumption, and also covers the institutional setting in the United States. Next it offers a model of pharmaceutical adoption. The next section provides the results of the analysis. Finally it concludes with a discussion of the results and the policy implications.

Keywords: health insurance coverage; drug use; new prescription drugs; statins; technology diffusion

Chapter.  6423 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.